Literature DB >> 29352995

Assessing risk of bias in studies that evaluate health care interventions: recommendations in the misinformation age.

Matthew J Page1, Isabelle Boutron2, Camilla Hansen3, Douglas G Altman4, Asbjørn Hróbjartsson3.   

Abstract

Methods to assess the risk of bias in a way that is reliable, reproducible. and transparent to readers, have evolved over time. Viswanathan et al. recently provided updated recommendations for assessing risk of bias in systematic reviews of health care interventions. We comment on their recommendations and discuss new tools in development that we, as co-convenors and coordinators of the Cochrane Bias Methods Group, are leading, which complement the methods recommended.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Bias; Methodology; Nonrandomized studies; Quality; Randomized trials; Systematic reviews

Mesh:

Year:  2018        PMID: 29352995     DOI: 10.1016/j.jclinepi.2018.01.004

Source DB:  PubMed          Journal:  J Clin Epidemiol        ISSN: 0895-4356            Impact factor:   6.437


  3 in total

1.  The efficacy and safety of hydroxychloroquine (HCQ) in treatment of COVID19 -a systematic review and meta-analysis.

Authors:  Anirban Hom Choudhuri; Sakshi Duggal; Bhuvna Ahuja; Partha Sarathi Biswas
Journal:  Indian J Med Microbiol       Date:  2021-03-26       Impact factor: 0.985

2.  Methods to improve medication adherence in patients with chronic inflammatory rheumatic diseases: a systematic literature review.

Authors:  Matthieu Lavielle; Déborah Puyraimond-Zemmour; Xavier Romand; Laure Gossec; Eric Senbel; Sophie Pouplin; Catherine Beauvais; Loriane Gutermann; Maryse Mezieres; Maxime Dougados; Anna Molto
Journal:  RMD Open       Date:  2018-07-27

3.  Influence and management of conflicts of interest in randomised clinical trials: qualitative interview study.

Authors:  Lasse Østengaard; Andreas Lundh; Tine Tjørnhøj-Thomsen; Suhayb Abdi; Mustafe H A Gelle; Lesley A Stewart; Isabelle Boutron; Asbjørn Hróbjartsson
Journal:  BMJ       Date:  2020-10-27
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.